This is part two of explaining the Adderall crisis. In the last episode, we discussed the brief history of amphetamines and why there is an Adderall shortage today. Here's a quick recap.:
• We learned that the natural stimulant Ephedra shortage in the 1920s likely caused the initial creation of synthetic amphetamines that we rely on to treat inattention and other conditions today.
• We also learned that amphetamines started as a decongestant and nasal spray used to create the amphetamine we know today by accident.
• We also learned that the short supply of amphetamine-based drugs in 2023 is very confusing since the supplies needed to make dextroamphetamine today are abundant because we switched to synthetic formulas about a hundred years ago.
• Contradictions from the DEA, FDA, and drug manufacturers complicate official explanations of the current drought.
• A post on Reddit broke the news of the Adderall shortage months later, and the FDA like felt pressured to make an official statement announcing the shortage. I say they likely felt pressured because when asked why they waited so long, their reply was that they didn't want to start a panic.
• The FDA claims that we're experiencing a nationwide shortage because of a company called Teva.
• Teva says they're experiencing problems because of a rising packaging line issue during covid. But then said the issue had been resolved and average production would resume in the summer of 2022, yet, here we are in the middle of 2023, and things seem to have seemingly become worse.
• We learned that the DEA regulates the supplies and quotas of the raw materials used to make amphetamine. They say there is no shortage of amphetamine and that, in fact, there is an excess and leftover supply of raw materials from the previous quota. Still, they need to find out which company has it.
Tune in!
Alpha Brain for focus
Download a free digital planner perfect for people with ADHD!
Binaural beats playlist
Abundant ADHD
ADHD Symptoms Quiz
Free EMDR therapy sim tool